help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goon, P. K. Y.
Right arrow Articles by Lip, G. Y. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goon, P. K. Y.
Right arrow Articles by Lip, G. Y. H.
American Journal of Respiratory and Critical Care Medicine Vol 175. pp. 1346, (2007)
© 2007 American Thoracic Society


Correspondence

Circulating Endothelial Cells in Obstructive Sleep Apnea: An Important Methodological Lesson

To the Editor:

We read with interest the recent article by El Solh and colleagues claiming a link between circulating endothelial cells (CECs) and obstructive sleep apnea (OSA) (1). However, two aspects of the methodology used by El Solh and coworkers warrant further discussion. CECs can be quantified by a number of methods, the commonest being immunomagnetic beads (IB) and flow cytometry. In both of these techniques, anti-CD146 (an endothelial-associated antigen) is frequently used (2). To ensure specificity for CECs, further markers or morphological features are identified. In the case of IB, secondary staining with lectin ulex europeaus is required. Similarly, with flow cytometry (FC), a multiparametric approach using multiple markers is essential.

El Solh and coworkers (1) rely solely on CD146 to discriminate CECs by FC. This technique is not supported by much of the recent literature, as CD146 is also now recognized to be present on other cells. This includes not only certain tumor lines (as highlighted by El Solh and coworkers in their article) but also a subpopulation of normal activated lymphocytes (35). Therefore, the concurrent use of a leukocyte discriminating marker (e.g., CD45 or a combination of CD33, CD19, CD3, CD14, CD21) is recommended. Thus, El Solh and coworkers may have inadvertently measured other leukocytes.

In addition, the fluorochrome conjugated to annexin V appears to have been an inappropriate choice. Importantly, the authors have used both anti-CD146 and annexin V conjugated to phycoerythrin (PE), together. This unfortunate error will undoubtedly have resulted in the failure to distinguish between the three possible groups of cells (CD146+, annexin V+, and CD146+/annexin V+ cells) during FC.

Given the intimate relationship between endothelial damage and cardiovascular disease, it seems logical that this process may also occur as a consequence of OSA alone. However, further exploration of this relationship must be based on contemporary methodological processes.

Patrick K. Y. Goon, Timothy Watson and Gregory Y. H. Lip

City Hospital, Birmingham, United Kingdom

FOOTNOTES

Conflict of Interest Statement: None of the authors has a financial relationship with a commercial entity that has an interest in the subject of this manuscript.

REFERENCES

  1. El Solh AA, Akinnusi ME, Baddoura FH, Mankowski CR. Endothelial cell apoptosis in obstructive sleep apnea: a link to endothelial dysfunction. Am J Respir Crit Care Med 2007;175:1186–1191.[Abstract/Free Full Text]
  2. Boos CJ, Lip GY, Blann AD. Circulating endothelial cells in cardiovascular disease. J Am Coll Cardiol 2006;48:1538–1547.[Abstract/Free Full Text]
  3. Goon PK, Boos CJ, Stonelake PS, Blann AD, Lip GY. Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: a methodological comparison. Thromb Haemost 2006;96:45–52.[Medline]
  4. Khan SS, Solomon MA, McCoy JP Jr. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom 2005;64:1–8.[Medline]
  5. Elshal MF, Khan SS, Takahashi Y, Solomon MA, McCoy JP Jr. CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood. Blood 2005;106:2923–2924.[Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goon, P. K. Y.
Right arrow Articles by Lip, G. Y. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goon, P. K. Y.
Right arrow Articles by Lip, G. Y. H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2007 American Thoracic Society